Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

Related Citations for PubMed (Select 22106917)

1.

Cytomegalovirus colitis and viremia from mycophenolate mofetil monotherapy in birdshot chorioretinopathy.

Pantanelli SM, Khalifa YM.

Ocul Immunol Inflamm. 2011 Dec;19(6):450-2. doi: 10.3109/09273948.2011.611961.

PMID:
22106917
2.

Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.

Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kisilisik AT, Trofe J, Alloway RR, Gaber LW, Gaber AO.

Transpl Infect Dis. 2001 Mar;3(1):8-15.

PMID:
11429034
3.

Cytomegalovirus colitis during mycophenolate mofetil therapy for Wegener's granulomatosis.

Woywodt A, Choi M, Schneider W, Kettritz R, Göbel U.

Am J Nephrol. 2000 Nov-Dec;20(6):468-72. Review.

PMID:
11146314
4.

Cytomegalovirus colitis in a CMV-seropositive renal transplant recipient on triple drug therapy (including mycophenolate).

Smak Gregoor PJ, van Gelder T, Abraham Tanis A, Chadha-Ajwani S, Klaassen RJ, Weimar W.

Nephrol Dial Transplant. 1997 Dec;12(12):2766-7. No abstract available.

5.

Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil.

Brum S, Nolasco F, Sousa J, Ferreira A, Possante M, Pinto JR, Barroso E, Santos JR.

Transplant Proc. 2008 Apr;40(3):752-4. doi: 10.1016/j.transproceed.2008.02.048.

PMID:
18455007
6.

Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.

Moreso F, Serón D, Morales JM, Cruzado JM, Gil-Vernet S, Pérez JL, Fulladosa X, Andrés A, Grinyó JM.

Clin Transplant. 1998 Jun;12(3):198-205.

PMID:
9642510
7.

Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction.

Giral M, Nguyen JM, Daguin P, Hourmant M, Cantarovich D, Dantal J, Blancho G, Josien R, Ancelet D, Soulillou JP.

J Am Soc Nephrol. 2001 Aug;12(8):1758-63.

8.

Successful conversion to everolimus after cytomegalovirus infection in a heart transplant recipient.

Imamura T, Shiga T, Kinugawa K, Kato N, Endo M, Inaba T, Maki H, Hatano M, Yao A, Hirata Y, Nagai R.

Int Heart J. 2012;53(3):199-201.

9.

[Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].

Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.

Przegl Lek. 2006;63 Suppl 3:44-8. Polish.

PMID:
16898486
10.

Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.

Sarmiento JM, Munn SR, Paya CV, Velosa JA, Nguyen JH.

Clin Transplant. 1998 Oct;12(5):371-4.

PMID:
9787943
11.
12.

Valganciclovir-induced leukopenia in liver transplant recipients: influence of concomitant use of mycophenolate mofetil.

Molina Perez E, Fernández Castroagudín J, Seijo Ríos S, Mera Calviño J, Tomé Martínez de Rituerto S, Otero Antón E, Bustamante Montalvo M, Varo Perez E.

Transplant Proc. 2009 Apr;41(3):1047-9. doi: 10.1016/j.transproceed.2009.02.033.

PMID:
19376423
13.

Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.

Bataille S, Moal V, Gaudart J, Indreies M, Purgus R, Dussol B, Zandotti C, Berland Y, Vacher-Coponat H.

Transpl Infect Dis. 2010 Dec;12(6):480-8. doi: 10.1111/j.1399-3062.2010.00533.x.

PMID:
20629971
14.

Development of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient.

Bienvenu B, Thervet E, Bedrossian J, Scieux C, Mazeron MC, Thouvenot D, Legendre C.

Transplantation. 2000 Jan 15;69(1):182-4.

PMID:
10653401
15.

Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus.

Gruber SA, Garnick J, Morawski K, Sillix DH, West MS, Granger DK, El-Amm JM, Alangaden GJ, Chandrasekar P, Haririan A.

Clin Transplant. 2005 Apr;19(2):273-8.

PMID:
15740567
16.

Primary cytomegalovirus infectious colitis complicating Crohn's disease successfully treated with oral valganciclovir.

Subramanian V, Finlayson C, Harrison T, Rice P, Pollok R.

J Crohns Colitis. 2010 Jun;4(2):199-202. doi: 10.1016/j.crohns.2009.11.004. Epub 2009 Dec 16.

17.

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients.

Sarmiento JM, Dockrell DH, Schwab TR, Munn SR, Paya CV.

Clin Transplant. 2000 Apr;14(2):136-8.

PMID:
10770418
18.

Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.

Sarmiento E, Fernàndez-Yáñez J, Muñoz P, Palomo J, Rodríguez-Molina JJ, Bermejo J, Catalan P, Bouza E, Fernández-Cruz E, Carbone J.

Int Immunopharmacol. 2005 Jan;5(1):97-101.

PMID:
15589466
19.

Hickam's dictum in a patient with diarrhea.

Feuerstein JD, Najarian R, Cheifetz AS.

Gastroenterology. 2013 Nov;145(5):942, 1165. doi: 10.1053/j.gastro.2013.07.013. Epub 2013 Sep 23. No abstract available. Erratum in: Gastroenterology. 2014 Sep;147(3):720. Feuerstien, Joseph D [corrected to Feuerstein, Joseph D].

PMID:
24070726
20.

Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone.

Lo A, Stratta RJ, Egidi MF, Kizilisik AT, Shokouh-Amiri MH, Grewal HP, Trofe J, Alloway RR, Gaber AO.

Transplant Proc. 2001 Feb-Mar;33(1-2):1796-8. No abstract available.

PMID:
11267516
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk